ADT: Catlin savours maiden win

ADTCombi - Day4 - 119Bogor, Indonesia, November 26: American John Catlin closed with a second consecutive four-under-par 67 to seal his maiden Asian Development Tour (ADT) victory at the Combiphar Golf Invitational on Saturday.

The 26-year-old Catlin, who started the day with a two-shot lead, sank four birdies against no bogey to claim a three-shot triumph with a 16-under-par 268 total at the Gunung Geulis Country Club situated in Bogor city.

Micah Lauren Shin, also of the United States, fired a 65 to grab a share of second place with Filipino stalwart Antonio Lascuna, who closed with a third straight 68, at the inaugural US$60,000 ADT event.

American Sam Cyr took fourth place on 273 following a 70 while Singapore’s Mitchell Slorach returned with a 71 to settle two shots back in fifth at the Combiphar Golf Invitational, which is the Tour’s second stop in Indonesia this season.

ADTCombi - Day4 - 007

“This win means so much to me. I have been through a lot in my life both personally and as a professional over the last three years so it means a lot to finally win,” said the Bangkok-based Catlin, who turned professional in 2013 and is playing in his second year in Asia.

Catlin continued his overnight lead by nailing two straight birdies on the front to turn in 33. He sank a 20-foot breaking putt for birdie on 15 but was tied for lead with his fast-charging playing partner Lascuna on 15-under with three holes to play.

Catlin, however, kept his cool and regained the outright lead straightaway following a two-shot swing for birdie on 16 as Lascuna stumbled with back-to-back bogeys.

“I just kept it the same as the last three days. I just stayed patient out there. I am glad it paid off,” added Catlin, who took home the winner’s prize purse of US$10,500 and received six Official World Golf Rankiing (OWGR) points courtesy of his win.

ADTCombi - Day4 - 114All ADT events offer OWGR points. The top six players and ties will also earn points based on a sliding scale. The top-five finishers on the final Order of Merit will secure their Asian Tour cards for 2017.

For more information on the ADT, please visit

Leading final round results:

268 - John CATLIN (USA) 70 64 67 67

271 - Micah Lauren SHIN (USA) 69 67 70 65, Antonio LASCUNA (PHI) 67 68 68 68

273 - Sam CYR (USA) 70 68 65 70

275 - Mitchell SLORACH (SGP) 70 63 71 71

276 - Atthaphon SRIBOONKAEW (THA) 69 75 66 66, Suradit YONGCHAROENCHAI (THA) 71 70 66 69, Panuwat MUENLEK (THA) 68 69 68 71

277 - Pannakorn UTHAIPAS (THA) 72 71 68 66, Chanat SAKULPOLPHAISAN (THA) 73 68 70 66, Victor OSTERBY (DEN) 68 72 70 67, Gavin GREEN (MAS) 73 69 66 69

278 - Brett MUNSON (USA) 72 69 69 68, Sorachut HANSAPIBAN (THA) 71 67 71 69, Tawan PHONGPHUN (THA) 71 69 67 71

279 - Naraajie E. RAMADHAN PUTRA (A) (INA) 70 71 70 68, Danny MASRIN (INA) 70 75 69 65, John Michael O’TOOLE (USA) 72 70 65 72

281 - Nicolas PAEZ (USA) 73 71 68 69, Kasidit LEPKURTE (THA) 71 69 72 69, Greg MOSS (USA) 75 69 67 70


About Combiphar

Combiphar was established in 1971 as pharmaceutical company. Today, Combiphar has transformed into a consumer healthcare modern company that manufactures and markets nearly 200 high quality and affordable prescription and over-the-counter drugs, such as OBH Combi cough syrup, joint pain reliever gel Joint Fit, green tea-based women cleaning products Privé, INSTO eyedrops, apta+ nutritious milk for adults, and Hezandra, supplements to protect the hepatic function. Equipped with the latest technologies and modern standard operating procedures, the Combiphar production facility located in Padalarang, West Java, has succeeded in acquiring the international certification ISO 14001:2004 for environmental management and the Therapeutic Goods Administration (TGA), which makes certain products of Combiphar able to be exported to Australia.

In addition, Combiphar also has its own R&D facility which focused on optimizing the quality of its prescription drugs to ensure that the drugs meet the Bio-Availability, BioEquivalence and Nanotechnology standards. Combiphar won the Super Brand 2015 in the “Consumer Healthcare Products and Service” category for OBH Combi & Insto. Combiphar currently occupies the top two major national pharmaceutical companies position as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity and customer loyalty. For more information, please visit:

About Asian Development Tour

The Asian Development Tour was launched in 2010 with the aim of creating a career pathway for professional golfers in Asia. Sanctioned by the Asian Tour, the Asian Development Tour will ultimately create a new playing platform for emerging stars from across Asia and around the world. Through the Asian Tour Qualifying School, players will qualify for the Asian Development Tour and enjoy the opportunity to hone their games and talent through a secondary circuit in Asia. Designed in the same structure as the Tour in America and European Challenge Tour, the Asian Development Tour is a stepping stone to the Asian Tour and the exciting world of international golf. The Asian Development Tour has been structured to ensure the best opportunities for its members. The leading five players on the Asian Development Tour will earn coveted Asian Tour cards for the following season, ensuring a proper career pathway for aspiring professionals. All ADT events receive Official World Golf Ranking points.